Global Biopharmaceuticals Market Growth (Status and Outlook) 2025-2031

December 2024 | 146 pages | ID: GE32551BCB77EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Biopharmaceuticals market size is predicted to grow from US$ 36930 million in 2025 to US$ 59580 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031.

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

United States market for Biopharmaceuticals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Biopharmaceuticals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Biopharmaceuticals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Biopharmaceuticals players cover Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Biopharmaceuticals Industry Forecast” looks at past sales and reviews total world Biopharmaceuticals sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceuticals sales for 2025 through 2031. With Biopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Biopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceuticals.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal Antibodies
• Interferon
• Colony-Stimulating Factor
• Erythropoietin
• Insulin
• Vaccines
• Growth Hormones
• Others

Segmentation by Application:

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Amgen
• AbbVie
• Sanofi-Aventis
• Johnson & Johnson
• Pfizer
• Novo Nordisk
• Eli Lilly
• Novartis
• Merck
• Sun
• 3sbio
• Changchun High Tech
• CP Guojian
• Biotech
• Gelgen
• Innovent
• Dong Bao
• Ganlee
• United Laboratories
• SANDOZ (NOVARTIS)
• Teva Pharmaceutical
• Hospira ?Pfizer?
• MYLAN
• Sun pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biopharmaceuticals Market Size (2020-2031)
  2.1.2 Biopharmaceuticals Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Biopharmaceuticals by Country/Region (2020, 2024 & 2031)
2.2 Biopharmaceuticals Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Interferon
  2.2.3 Colony-Stimulating Factor
  2.2.4 Erythropoietin
  2.2.5 Insulin
  2.2.6 Vaccines
  2.2.7 Growth Hormones
  2.2.8 Others
2.3 Biopharmaceuticals Market Size by Type
  2.3.1 Biopharmaceuticals Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Biopharmaceuticals Market Size Market Share by Type (2020-2025)
2.4 Biopharmaceuticals Segment by Application
  2.4.1 Tumor
  2.4.2 Diabetes
  2.4.3 Cardiovascular
  2.4.4 Hemophilia
  2.4.5 Others
2.5 Biopharmaceuticals Market Size by Application
  2.5.1 Biopharmaceuticals Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Biopharmaceuticals Market Size Market Share by Application (2020-2025)

3 BIOPHARMACEUTICALS MARKET SIZE BY PLAYER

3.1 Biopharmaceuticals Market Size Market Share by Player
  3.1.1 Global Biopharmaceuticals Revenue by Player (2020-2025)
  3.1.2 Global Biopharmaceuticals Revenue Market Share by Player (2020-2025)
3.2 Global Biopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOPHARMACEUTICALS BY REGION

4.1 Biopharmaceuticals Market Size by Region (2020-2025)
4.2 Global Biopharmaceuticals Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceuticals Market Size Growth (2020-2025)
4.4 APAC Biopharmaceuticals Market Size Growth (2020-2025)
4.5 Europe Biopharmaceuticals Market Size Growth (2020-2025)
4.6 Middle East & Africa Biopharmaceuticals Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Biopharmaceuticals Market Size by Country (2020-2025)
5.2 Americas Biopharmaceuticals Market Size by Type (2020-2025)
5.3 Americas Biopharmaceuticals Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biopharmaceuticals Market Size by Region (2020-2025)
6.2 APAC Biopharmaceuticals Market Size by Type (2020-2025)
6.3 APAC Biopharmaceuticals Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biopharmaceuticals Market Size by Country (2020-2025)
7.2 Europe Biopharmaceuticals Market Size by Type (2020-2025)
7.3 Europe Biopharmaceuticals Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biopharmaceuticals by Region (2020-2025)
8.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOPHARMACEUTICALS MARKET FORECAST

10.1 Global Biopharmaceuticals Forecast by Region (2026-2031)
  10.1.1 Global Biopharmaceuticals Forecast by Region (2026-2031)
  10.1.2 Americas Biopharmaceuticals Forecast
  10.1.3 APAC Biopharmaceuticals Forecast
  10.1.4 Europe Biopharmaceuticals Forecast
  10.1.5 Middle East & Africa Biopharmaceuticals Forecast
10.2 Americas Biopharmaceuticals Forecast by Country (2026-2031)
  10.2.1 United States Market Biopharmaceuticals Forecast
  10.2.2 Canada Market Biopharmaceuticals Forecast
  10.2.3 Mexico Market Biopharmaceuticals Forecast
  10.2.4 Brazil Market Biopharmaceuticals Forecast
10.3 APAC Biopharmaceuticals Forecast by Region (2026-2031)
  10.3.1 China Biopharmaceuticals Market Forecast
  10.3.2 Japan Market Biopharmaceuticals Forecast
  10.3.3 Korea Market Biopharmaceuticals Forecast
  10.3.4 Southeast Asia Market Biopharmaceuticals Forecast
  10.3.5 India Market Biopharmaceuticals Forecast
  10.3.6 Australia Market Biopharmaceuticals Forecast
10.4 Europe Biopharmaceuticals Forecast by Country (2026-2031)
  10.4.1 Germany Market Biopharmaceuticals Forecast
  10.4.2 France Market Biopharmaceuticals Forecast
  10.4.3 UK Market Biopharmaceuticals Forecast
  10.4.4 Italy Market Biopharmaceuticals Forecast
  10.4.5 Russia Market Biopharmaceuticals Forecast
10.5 Middle East & Africa Biopharmaceuticals Forecast by Region (2026-2031)
  10.5.1 Egypt Market Biopharmaceuticals Forecast
  10.5.2 South Africa Market Biopharmaceuticals Forecast
  10.5.3 Israel Market Biopharmaceuticals Forecast
  10.5.4 Turkey Market Biopharmaceuticals Forecast
10.6 Global Biopharmaceuticals Forecast by Type (2026-2031)
10.7 Global Biopharmaceuticals Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Biopharmaceuticals Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Biopharmaceuticals Product Offered
  11.1.3 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Biopharmaceuticals Product Offered
  11.2.3 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments
11.3 AbbVie
  11.3.1 AbbVie Company Information
  11.3.2 AbbVie Biopharmaceuticals Product Offered
  11.3.3 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AbbVie Main Business Overview
  11.3.5 AbbVie Latest Developments
11.4 Sanofi-Aventis
  11.4.1 Sanofi-Aventis Company Information
  11.4.2 Sanofi-Aventis Biopharmaceuticals Product Offered
  11.4.3 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sanofi-Aventis Main Business Overview
  11.4.5 Sanofi-Aventis Latest Developments
11.5 Johnson & Johnson
  11.5.1 Johnson & Johnson Company Information
  11.5.2 Johnson & Johnson Biopharmaceuticals Product Offered
  11.5.3 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Johnson & Johnson Main Business Overview
  11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Biopharmaceuticals Product Offered
  11.6.3 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Novo Nordisk
  11.7.1 Novo Nordisk Company Information
  11.7.2 Novo Nordisk Biopharmaceuticals Product Offered
  11.7.3 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novo Nordisk Main Business Overview
  11.7.5 Novo Nordisk Latest Developments
11.8 Eli Lilly
  11.8.1 Eli Lilly Company Information
  11.8.2 Eli Lilly Biopharmaceuticals Product Offered
  11.8.3 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Eli Lilly Main Business Overview
  11.8.5 Eli Lilly Latest Developments
11.9 Novartis
  11.9.1 Novartis Company Information
  11.9.2 Novartis Biopharmaceuticals Product Offered
  11.9.3 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Novartis Main Business Overview
  11.9.5 Novartis Latest Developments
11.10 Merck
  11.10.1 Merck Company Information
  11.10.2 Merck Biopharmaceuticals Product Offered
  11.10.3 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Merck Main Business Overview
  11.10.5 Merck Latest Developments
11.11 Sun
  11.11.1 Sun Company Information
  11.11.2 Sun Biopharmaceuticals Product Offered
  11.11.3 Sun Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Sun Main Business Overview
  11.11.5 Sun Latest Developments
11.12 3sbio
  11.12.1 3sbio Company Information
  11.12.2 3sbio Biopharmaceuticals Product Offered
  11.12.3 3sbio Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 3sbio Main Business Overview
  11.12.5 3sbio Latest Developments
11.13 Changchun High Tech
  11.13.1 Changchun High Tech Company Information
  11.13.2 Changchun High Tech Biopharmaceuticals Product Offered
  11.13.3 Changchun High Tech Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Changchun High Tech Main Business Overview
  11.13.5 Changchun High Tech Latest Developments
11.14 CP Guojian
  11.14.1 CP Guojian Company Information
  11.14.2 CP Guojian Biopharmaceuticals Product Offered
  11.14.3 CP Guojian Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 CP Guojian Main Business Overview
  11.14.5 CP Guojian Latest Developments
11.15 Biotech
  11.15.1 Biotech Company Information
  11.15.2 Biotech Biopharmaceuticals Product Offered
  11.15.3 Biotech Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Biotech Main Business Overview
  11.15.5 Biotech Latest Developments
11.16 Gelgen
  11.16.1 Gelgen Company Information
  11.16.2 Gelgen Biopharmaceuticals Product Offered
  11.16.3 Gelgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Gelgen Main Business Overview
  11.16.5 Gelgen Latest Developments
11.17 Innovent
  11.17.1 Innovent Company Information
  11.17.2 Innovent Biopharmaceuticals Product Offered
  11.17.3 Innovent Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Innovent Main Business Overview
  11.17.5 Innovent Latest Developments
11.18 Dong Bao
  11.18.1 Dong Bao Company Information
  11.18.2 Dong Bao Biopharmaceuticals Product Offered
  11.18.3 Dong Bao Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Dong Bao Main Business Overview
  11.18.5 Dong Bao Latest Developments
11.19 Ganlee
  11.19.1 Ganlee Company Information
  11.19.2 Ganlee Biopharmaceuticals Product Offered
  11.19.3 Ganlee Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Ganlee Main Business Overview
  11.19.5 Ganlee Latest Developments
11.20 United Laboratories
  11.20.1 United Laboratories Company Information
  11.20.2 United Laboratories Biopharmaceuticals Product Offered
  11.20.3 United Laboratories Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 United Laboratories Main Business Overview
  11.20.5 United Laboratories Latest Developments
11.21 SANDOZ (NOVARTIS)
  11.21.1 SANDOZ (NOVARTIS) Company Information
  11.21.2 SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered
  11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 SANDOZ (NOVARTIS) Main Business Overview
  11.21.5 SANDOZ (NOVARTIS) Latest Developments
11.22 Teva Pharmaceutical
  11.22.1 Teva Pharmaceutical Company Information
  11.22.2 Teva Pharmaceutical Biopharmaceuticals Product Offered
  11.22.3 Teva Pharmaceutical Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 Teva Pharmaceutical Main Business Overview
  11.22.5 Teva Pharmaceutical Latest Developments
11.23 Hospira ?Pfizer?
  11.23.1 Hospira ?Pfizer? Company Information
  11.23.2 Hospira ?Pfizer? Biopharmaceuticals Product Offered
  11.23.3 Hospira ?Pfizer? Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.23.4 Hospira ?Pfizer? Main Business Overview
  11.23.5 Hospira ?Pfizer? Latest Developments
11.24 MYLAN
  11.24.1 MYLAN Company Information
  11.24.2 MYLAN Biopharmaceuticals Product Offered
  11.24.3 MYLAN Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.24.4 MYLAN Main Business Overview
  11.24.5 MYLAN Latest Developments
11.25 Sun pharma
  11.25.1 Sun pharma Company Information
  11.25.2 Sun pharma Biopharmaceuticals Product Offered
  11.25.3 Sun pharma Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
  11.25.4 Sun pharma Main Business Overview
  11.25.5 Sun pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biopharmaceuticals Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biopharmaceuticals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Interferon
Table 5. Major Players of Colony-StimulatingFactor
Table 6. Major Players of Erythropoietin
Table 7. Major Players of Insulin
Table 8. Major Players of Vaccines
Table 9. Major Players of Growth Hormones
Table 10. Major Players of Others
Table 11. Biopharmaceuticals Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Biopharmaceuticals Market Size byType (2020-2025) & ($ millions)
Table 13. Global Biopharmaceuticals Market Size Market Share byType (2020-2025)
Table 14. Biopharmaceuticals Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 15. Global Biopharmaceuticals Market Size by Application (2020-2025) & ($ millions)
Table 16. Global Biopharmaceuticals Market Size Market Share by Application (2020-2025)
Table 17. Global Biopharmaceuticals Revenue by Player (2020-2025) & ($ millions)
Table 18. Global Biopharmaceuticals Revenue Market Share by Player (2020-2025)
Table 19. Biopharmaceuticals Key Players Head office and Products Offered
Table 20. Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Biopharmaceuticals Market Size by Region (2020-2025) & ($ millions)
Table 24. Global Biopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 25. Global Biopharmaceuticals Revenue by Country/Region (2020-2025) & ($ millions)
Table 26. Global Biopharmaceuticals Revenue Market Share by Country/Region (2020-2025)
Table 27. Americas Biopharmaceuticals Market Size by Country (2020-2025) & ($ millions)
Table 28. Americas Biopharmaceuticals Market Size Market Share by Country (2020-2025)
Table 29. Americas Biopharmaceuticals Market Size byType (2020-2025) & ($ millions)
Table 30. Americas Biopharmaceuticals Market Size Market Share byType (2020-2025)
Table 31. Americas Biopharmaceuticals Market Size by Application (2020-2025) & ($ millions)
Table 32. Americas Biopharmaceuticals Market Size Market Share by Application (2020-2025)
Table 33. APAC Biopharmaceuticals Market Size by Region (2020-2025) & ($ millions)
Table 34. APAC Biopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 35. APAC Biopharmaceuticals Market Size byType (2020-2025) & ($ millions)
Table 36. APAC Biopharmaceuticals Market Size by Application (2020-2025) & ($ millions)
Table 37. Europe Biopharmaceuticals Market Size by Country (2020-2025) & ($ millions)
Table 38. Europe Biopharmaceuticals Market Size Market Share by Country (2020-2025)
Table 39. Europe Biopharmaceuticals Market Size byType (2020-2025) & ($ millions)
Table 40. Europe Biopharmaceuticals Market Size by Application (2020-2025) & ($ millions)
Table 41. Middle East & Africa Biopharmaceuticals Market Size by Region (2020-2025) & ($ millions)
Table 42. Middle East & Africa Biopharmaceuticals Market Size byType (2020-2025) & ($ millions)
Table 43. Middle East & Africa Biopharmaceuticals Market Size by Application (2020-2025) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceuticals
Table 45. Key Market Challenges & Risks of Biopharmaceuticals
Table 46. Key IndustryTrends of Biopharmaceuticals
Table 47. Global Biopharmaceuticals Market SizeForecast by Region (2026-2031) & ($ millions)
Table 48. Global Biopharmaceuticals Market Size Market ShareForecast by Region (2026-2031)
Table 49. Global Biopharmaceuticals Market SizeForecast byType (2026-2031) & ($ millions)
Table 50. Global Biopharmaceuticals Market SizeForecast by Application (2026-2031) & ($ millions)
Table 51. Roche Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 52. Roche Biopharmaceuticals Product Offered
Table 53. Roche Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Amgen Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 57. Amgen Biopharmaceuticals Product Offered
Table 58. Amgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Amgen Main Business
Table 60. Amgen Latest Developments
Table 61. AbbVie Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 62. AbbVie Biopharmaceuticals Product Offered
Table 63. AbbVie Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. AbbVie Main Business
Table 65. AbbVie Latest Developments
Table 66. Sanofi-Aventis Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 67. Sanofi-Aventis Biopharmaceuticals Product Offered
Table 68. Sanofi-Aventis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sanofi-Aventis Main Business
Table 70. Sanofi-Aventis Latest Developments
Table 71. Johnson & Johnson Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 72. Johnson & Johnson Biopharmaceuticals Product Offered
Table 73. Johnson & Johnson Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Johnson & Johnson Main Business
Table 75. Johnson & Johnson Latest Developments
Table 76. Pfizer Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 77. Pfizer Biopharmaceuticals Product Offered
Table 78. Pfizer Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. Novo Nordisk Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 82. Novo Nordisk Biopharmaceuticals Product Offered
Table 83. Novo Nordisk Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Novo Nordisk Main Business
Table 85. Novo Nordisk Latest Developments
Table 86. Eli Lilly Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 87. Eli Lilly Biopharmaceuticals Product Offered
Table 88. Eli Lilly Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Eli Lilly Main Business
Table 90. Eli Lilly Latest Developments
Table 91. Novartis Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 92. Novartis Biopharmaceuticals Product Offered
Table 93. Novartis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Merck Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 97. Merck Biopharmaceuticals Product Offered
Table 98. Merck Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Sun Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 102. Sun Biopharmaceuticals Product Offered
Table 103. Sun Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Sun Main Business
Table 105. Sun Latest Developments
Table 106. 3sbio Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 107. 3sbio Biopharmaceuticals Product Offered
Table 108. 3sbio Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. 3sbio Main Business
Table 110. 3sbio Latest Developments
Table 111. Changchun HighTech Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 112. Changchun HighTech Biopharmaceuticals Product Offered
Table 113. Changchun HighTech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Changchun HighTech Main Business
Table 115. Changchun HighTech Latest Developments
Table 116. CP Guojian Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 117. CP Guojian Biopharmaceuticals Product Offered
Table 118. CP Guojian Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. CP Guojian Main Business
Table 120. CP Guojian Latest Developments
Table 121. Biotech Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 122. Biotech Biopharmaceuticals Product Offered
Table 123. Biotech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Biotech Main Business
Table 125. Biotech Latest Developments
Table 126. Gelgen Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 127. Gelgen Biopharmaceuticals Product Offered
Table 128. Gelgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Gelgen Main Business
Table 130. Gelgen Latest Developments
Table 131. Innovent Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 132. Innovent Biopharmaceuticals Product Offered
Table 133. Innovent Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Innovent Main Business
Table 135. Innovent Latest Developments
Table 136. Dong Bao Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 137. Dong Bao Biopharmaceuticals Product Offered
Table 138. Dong Bao Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Dong Bao Main Business
Table 140. Dong Bao Latest Developments
Table 141. Ganlee Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 142. Ganlee Biopharmaceuticals Product Offered
Table 143. Ganlee Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Ganlee Main Business
Table 145. Ganlee Latest Developments
Table 146. United Laboratories Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 147. United Laboratories Biopharmaceuticals Product Offered
Table 148. United Laboratories Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. United Laboratories Main Business
Table 150. United Laboratories Latest Developments
Table 151. SANDOZ (NOVARTIS) Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 152. SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered
Table 153. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 154. SANDOZ (NOVARTIS) Main Business
Table 155. SANDOZ (NOVARTIS) Latest Developments
Table 156.Teva Pharmaceutical Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 157.Teva Pharmaceutical Biopharmaceuticals Product Offered
Table 158.Teva Pharmaceutical Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 159.Teva Pharmaceutical Main Business
Table 160.Teva Pharmaceutical Latest Developments
Table 161. Hospira ?Pfizer? Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 162. Hospira ?Pfizer? Biopharmaceuticals Product Offered
Table 163. Hospira ?Pfizer? Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 164. Hospira ?Pfizer? Main Business
Table 165. Hospira ?Pfizer? Latest Developments
Table 166. MYLAN Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 167. MYLAN Biopharmaceuticals Product Offered
Table 168. MYLAN Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 169. MYLAN Main Business
Table 170. MYLAN Latest Developments
Table 171. Sun pharma Details, CompanyType, Biopharmaceuticals Area Served and Its Competitors
Table 172. Sun pharma Biopharmaceuticals Product Offered
Table 173. Sun pharma Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 174. Sun pharma Main Business
Table 175. Sun pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceuticals Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biopharmaceuticals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biopharmaceuticals Sales Market Share by Country/Region (2024)
Figure 8. Biopharmaceuticals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biopharmaceuticals Market Size Market Share byType in 2024
Figure 10. Biopharmaceuticals inTumor
Figure 11. Global Biopharmaceuticals Market:Tumor (2020-2025) & ($ millions)
Figure 12. Biopharmaceuticals in Diabetes
Figure 13. Global Biopharmaceuticals Market: Diabetes (2020-2025) & ($ millions)
Figure 14. Biopharmaceuticals in Cardiovascular
Figure 15. Global Biopharmaceuticals Market: Cardiovascular (2020-2025) & ($ millions)
Figure 16. Biopharmaceuticals in Hemophilia
Figure 17. Global Biopharmaceuticals Market: Hemophilia (2020-2025) & ($ millions)
Figure 18. Biopharmaceuticals in Others
Figure 19. Global Biopharmaceuticals Market: Others (2020-2025) & ($ millions)
Figure 20. Global Biopharmaceuticals Market Size Market Share by Application in 2024
Figure 21. Global Biopharmaceuticals Revenue Market Share by Player in 2024
Figure 22. Global Biopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 23. Americas Biopharmaceuticals Market Size 2020-2025 ($ millions)
Figure 24. APAC Biopharmaceuticals Market Size 2020-2025 ($ millions)
Figure 25. Europe Biopharmaceuticals Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Biopharmaceuticals Market Size 2020-2025 ($ millions)
Figure 27. Americas Biopharmaceuticals Value Market Share by Country in 2024
Figure 28. United States Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Biopharmaceuticals Market Size Market Share by Region in 2024
Figure 33. APAC Biopharmaceuticals Market Size Market Share byType (2020-2025)
Figure 34. APAC Biopharmaceuticals Market Size Market Share by Application (2020-2025)
Figure 35. China Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 39. India Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Biopharmaceuticals Market Size Market Share by Country in 2024
Figure 42. Europe Biopharmaceuticals Market Size Market Share byType (2020-2025)
Figure 43. Europe Biopharmaceuticals Market Size Market Share by Application (2020-2025)
Figure 44. Germany Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 45.France Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Biopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Biopharmaceuticals Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Biopharmaceuticals Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Biopharmaceuticals Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 58. APAC Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 59. Europe Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 61. United States Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 62. Canada Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 63. Mexico Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 64. Brazil Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 65. China Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 66. Japan Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 67. Korea Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 69. India Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 70. Australia Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 71. Germany Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 72.France Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 73. UK Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 74. Italy Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 75. Russia Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 76. Egypt Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 77. South Africa Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 78. Israel Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 79.Turkey Biopharmaceuticals Market Size 2026-2031 ($ millions)
Figure 80. Global Biopharmaceuticals Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Biopharmaceuticals Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Biopharmaceuticals Market Size 2026-2031 ($ millions)